2-Dimethylaminoethanol (Deanol) in Huntington's chorea

A double-blind crossover trial with 2-dimethylaminoethanol (Deanol), a possible precursor of brain acetylcholine, was carried out in nine patients with Huntington's chorea. It was found to be ineffective in inducing any alteration in hyperkinesia.

Saved in:
Bibliographic Details
Published inJournal of neurology, neurosurgery and psychiatry Vol. 41; no. 12; pp. 1114 - 1118
Main Authors Caraceni, T. A., Girotti, F., Celano, I., Parati, E., Balboni, L.
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.12.1978
BMJ Publishing Group LTD
Subjects
Adolescent
Adult
Clinical Trials as Topic
Deanol - therapeutic use
Double-Blind Method
Ethanolamines - therapeutic use
Female
Haloperidol - therapeutic use
Humans
Huntington Disease - drug therapy
Male
Middle Aged
Online AccessGet full text

Cover

More Information
Summary:A double-blind crossover trial with 2-dimethylaminoethanol (Deanol), a possible precursor of brain acetylcholine, was carried out in nine patients with Huntington's chorea. It was found to be ineffective in inducing any alteration in hyperkinesia.
Bibliography:href:jnnp-41-1114.pdf
istex:6693085BB8B010C635D7B033FFA3CE0FFA813B87
local:jnnp;41/12/1114
PMID:153384
ark:/67375/NVC-ZDN65PSS-X
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0022-3050
1468-330X
DOI:10.1136/jnnp.41.12.1114